Erratum to: Long-term ethanol exposure causes human liver cancer cells to become resistant to mitomycin C treatment through the inactivation of bad-mediated apoptosis (Molecular Carcinogenesis, (2010), 49, 8, (728–738), 10.1002/mc.20648);Long-term ethanol exposure causes human liver cancer cells to become resistant to mitomycin c treatment through the inactivation of bad-mediated apoptosis

Molecular Carcinogenesis

Volumn 49, Issue 8, 2010, Pages 728-738

  Huang, Ching Shui ^a,b   Lee, Yi Ru ^c   Chen, Ching Shyang ^b,d   Tu, Shih Hsin ^a,b   Wang, Ying Jan ^e   Lee, Chia Hwa ^c   Chen, Li Ching ^c   Chang, Hui Wen ^d   Chang, Chien Hsi ^d   Chih Ming, Su ^f   Wu, Chih Hsiung ^f   Ho, Yuan Soon ^c,d  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^f Shuang Ho Hospital   (Taiwan)

Author keywords

Apoptosis; Bad phosphorylation; Ethanol consumption; Liver cancer; Mitomycin C

Indexed keywords

CASPASE 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOMYCIN C; PROTEIN 14 3 3; PROTEIN BAD; PROTEIN KINASE B; PROTEIN P16; PROTEIN P21; PROTEIN P27;

ALCOHOL CONSUMPTION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE S PHASE; FLOW CYTOMETRY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIVER CANCER; LIVER CELL CARCINOMA; LONG TERM EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR XENOGRAFT;

HEPATITIS B VIRUS; MUS;

EID: 77956135374     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22641     Document Type: Erratum

References (46)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-543.
2. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. NIH conference. Hepatocellular carcinoma. Ann Intern Med 1988;108:390-401.
3. Wu HC, Wang Q, Yang HI, et al. Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan. Cancer Epidemiol Biomarkers Prev 2009;18:846-853.
4. Korourian S, Hakkak R, Ronis MJ, et al. Diet and risk of ethanol-induced hepatotoxicity: Carbohydrate - fat relationships in rats. Toxicol Sci 1999;47:110-117. (Pubitemid 29214238)
5. Raucy JL, Lasker J, Ozaki K, Zoleta V. Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes. Toxicol Sci 2004;79:233-241.
6. Navasumrit P, Ward TH, Dodd NJ, O'Connor PJ. Ethanol-induced free radicals and hepatic DNA strand breaks are prevented in vivo by antioxidants: Effects of acute and chronic ethanol exposure. Carcinogenesis 2000;21:93-99.
7. Lu Y, Zhuge J, Wang X, Bai J, Cederbaum AI. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice. Hepatology 2008;47:1483-1494. (Pubitemid 351702732)
8. Guengerich FP, Shimada T, Yun CH, et al. Interactions of ingested food, beverage, and tobacco components involving human cytochrome P4501A2, 2A6, 2E1, and 3A4 enzymes. Environ Health Perspect 1994;102:49-53.
9. Rump AF, Woschee U, Theisohn M, et al. Pharmacokinetics of intra-arterial mitomycin C in the chemoembolization treatment of liver metastases with polyvinylalcohol or degradable starch microspheres. Eur J Clin Pharmacol 2002;58:459-465.
10. Wils J, Grave W, van Breda Vriesman PJ. Haemolytic-uraemic syndrome associated with mitomycin-C treatment. Neth J Med 1987;30:32-35.
11. Ishida K, Hirooka M, Hiraoka A, et al. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil. Jpn J Clin Oncol 2008;38:596-603.
12. Bandera EV, August DA. Alcohol consumption and breast cancer survival. J Clin Oncol 2009;27:1727; author reply 1728.
13. McKillop IH, Schrum LW. Role of alcohol in liver carcinogenesis. Semin Liver Dis 2009;29:222-232.
14. Chen CS, Wu CH, Lai YC, et al. NF-kappaB-activated tissue transglutaminase is involved in ethanol-induced hepatic injury and the possible role of propolis in preventing fibrogenesis. Toxicology 2008;246:148-157.
15. Wu CH, Ho YS, Tsai CY, et al. In vitro and in vivo study of phloretin-induced apoptosis in human liver cancer cells involving inhibition of type II glucose transporter. Int J Cancer 2009;124:2210-2219.
16. Yang KC, Tsai CY, Wang YJ, et al. Apple polyphenol phloretin potentiates the anticancer actions of paclitaxel through induction of apoptosis in human hep G2 cells. Mol Carcinog 2009;48:420-431.
17. Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 1980;209:497-499.
18. Adickes ED, Mollner TJ, Lockwood SK. Closed chamber system for delivery of ethanol to cell cultures. Alcohol Alcohol 1988;23:377-381.
19. Rodriguez FD, Simonsson P, Alling C. A method for maintaining constant ethanol concentrations in cell culture media. Alcohol Alcohol 1992;27:309-313.
20. Eysseric H, Gonthier B, Soubeyran A, Bessard G, Saxod R, Barret L. There is not simple method to maintain a constant ethanol concentration in long-term cell culture: Keys to a solution applied to the survey of astrocytic ethanol absorption. Alcohol 1997;14:111-115. (Pubitemid 27147330)
21. Lee WS, Chen RJ, Wang YJ, et al. In vitro and in vivo studies of the anticancer action of terbinafine in human cancer cell lines: G0/G1 p53-associated cell cycle arrest. Int J Cancer 2003;106:125-137.
22. Huang CS, Ho WL, Lee WS, et al. SP1-regulated p27/Kip1 gene expression is involved in terbinafine-induced human A431 cancer cell differentiation: An in vitro and in vivo study. Biochem Pharmacol 2008;75:1783-1796.
23. Chou YH, Ho YS, Wu CC, et al. Tubulozole-induced G2/M cell cycle arrest in human colon cancer cells through formation of microtubule polymerization mediated by ERK1/2 and Chk1 kinase activation. Food Chem Toxicol 2007;45:1356-1367.
24. Fromenty B, Vadrot N, Massart J, et al. Chronic ethanol consumption lessens the gain of body weight, liver triglycerides, and diabetes in obese ob/ob mice. J Pharmacol Exp Ther 2009;331:23-34.
25. Coats S, Flanagan WM, Nourse J, Roberts JM. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 1996;272:877-880.
26. Liu C, Russell RM, Seitz HK, Wang XD. Ethanol enhances retinoic acid metabolism into polar metabolites in rat liver via induction of cytochrome P4502E1. Gastroenterology 2001;120:179-189. (Pubitemid 32061882)
27. Wang XD. Retinoids and alcohol-related carcinogenesis. J Nutr 2003;133:287S-290S.
28. Lee CS, Park SY, Ko HH, Han ES. Effect of change in cellular GSH levels on mitochondrial damage and cell viability loss due to mitomycin c in small cell lung cancer cells. Biochem Pharmacol 2004;68:1857-1867.
29. Hayakawa J, Ohmichi M, Kurachi H, et al. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin. Cancer Res 2000;60:5988-5994.
30. Voigt MD. Alcohol in hepatocellular cancer. Clin Liver Dis 2005;9:151-169.
31. Ingram LO, Ley KD, Hoffmann EM. Drug-induced changes in lipid composition of E. coli and of mammalian cells in culture: Ethanol, pentobarbital, and chlorpromazine. Life Sci 1978;22:489-494.
32. Lopez CH, Suzuki-Kemmelmeier F, Constantin J, Bracht A. Zonation of the action of ethanol on gluconeogenesis and ketogenesis studied in the bivascularly perfused rat liver. Chem Biol Interact 2009;177:89-95.
33. Baan R, Straif K, Grosse Y, et al. Carcinogenicity of alcoholic beverages. Lancet Oncol 2007;8:292-293.
34. Couch DB, Baker RC. Ethanol-enhanced cytotoxicity of alkylating agents. Alcohol Clin Exp Res 2002;26:381-385.
35. Marietta C, Thompson LH, Lamerdin JE, Brooks PJ. Acetaldehyde stimulates FANCD2 monoubiquitination, H2AX phosphorylation, and BRCA1 phosphorylation in human cells in vitro: Implications for alcohol-related carcinogenesis. Mutat Res 2009;664:77-83.
36. Witte MH, Borgs P, Way DL, Ramirez G, Jr., Bernas MJ, Witte CL. Alcohol, hepatic sinusoidal microcirculation, and chronic liver disease. Alcohol 1992;9:473-480.
37. Arteel GE. Alcohol-induced oxidative stress in the liver: In vivo measurements. Methods Mol Biol 2008;447:185-197.
38. Pritsos CA, Sartorelli AC. Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics. Cancer Res 1986;46:3528-3532.
39. Gyves JW, Ensminger WD, VanHarken D, Niederhuber J, Stetson P, Walker S. Improved regional selectivity of hepatic arterial mitomycin by starch microspheres. Clin Pharmacol Ther 1983;34:259-265.
40. Kennedy KA, Rockwell S, Sartorelli AC. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res 1980;40:2356-2360.
41. Rooseboom M, Commandeur JN, Vermeulen NP. Enzymecatalyzed activation of anticancer prodrugs. Pharmacol Rev 2004;56:53-102.
42. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997;278:687-689. (Pubitemid 27464966)
43. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996;87:619-628.
44. Siler-Marsiglio KI, Madorsky I, Pan Q, et al. Effects of acute ethanol exposure on regulatory mechanisms of Bcl-2-associated apoptosis promoter, bad, in neonatal rat cerebellum: Differential effects during vulnerable and resistant developmental periods. Alcohol Clin Exp Res 2006;30:1031-1038.
45. Datta SR, Katsov A, Hu L, et al. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 2000;6:41-51.
46. Han JY, Jeong EY, Kim YS, et al. C-jun N-terminal kinase regulates the interaction between 14-3-3 and Bad in ethanol-induced cell death. J Neurosci Res 2008;86:3221-3229.